is the intersection between Clinical Pharmacology and Nephrology
[Atkinson 2009] and considers the following topics:
• Mechanisms of drug elimination by the kidneys
• Drug therapy and kidney transplantation
• Drug therapy of co-morbidity in kidney patients
• Renal toxicity of drugs
Atkinson AJ Jr, Huang SM. Nephropharmacology: drugs and
Clin Pharmacol Ther 2009;86:453-6.
is the NephroPharmacology Group?
Group consists of independent
various and diversified scientific interest. Our expertise includes
internal medicine, nephrology, clinical pharmacology, and transplant
Historically we started regular meetings in 1990 with a main lecture
given by Luzius Dettli. A loose group was formed thereafter and the
founding members were, Erich Keller, Frieder Keller, Teut Risler, and
later David Czock.
is the NephroPharmacology Meeting?
Meeting is organized once per year by members
of the NephroPharmacology
Group. The meeting has the character of a
workshop where own research projects can be presented and discussed
with experts in the field.
We started in 1990 with specific aspects of pharmacokinetics and drug
dosage adjustment in patients with impaired kidney function. In
subsequent workshops the nephropharmacological topics expanded to cover
the intensive care unit and during renal replacement therapy,
immunosuppression and kidney transplantation, therapeutic drug
monitoring, and pharmacovigilance. In addition, nephrotoxicity and
adverse drug reactions were addressed along with drug therapy of
primary kidney diseases and of the co-morbidities in kidney patients.
Meeting is traditionally organized in such a way that
attendees will have an opportunity to give a talk. However,
participants joining the meeting for listening and/ or engaging into
discussions without presenting own results are most welcome. In
addition, it is our traditional rule to publish
selected papers that were presented at the NephroPharmacology Meeting
in a scientific journal.